imipenem, anhydrous has been researched along with Infant, Premature, Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barsaoui, S; Ben Jaballah, N; Bousnina, S; Bouziri, A; Hajji, N; Hariga, D; Kechrid, A; Sammoud, A; Smaoui, H | 1 |
| Manzar, S | 1 |
| Grayson, ML; Stuart, RL; Turnidge, J | 1 |
| Bhutta, ZA | 1 |
| Böswald, M; Döbig, C; Guggenbichler, JP; Kändler, C; Krüger, C; Scharf, J; Soergel, F; Zink, S | 1 |
| Goodwin, CS; Nsanze, H; Topley, J; Varady, E; Worsley, BW | 1 |
| Fujimoto, T; Kawakami, A; Koga, T; Motohiro, T; Oda, K; Sakata, Y; Shimada, Y; Tanaka, K; Tominaga, K; Tomita, S | 1 |
| Aufrant, C; Bompard, Y; Chastel, A; Gantzer, A; Lambert, T; Voinnesson, A | 1 |
| Akita, H; Ishizuka, Y; Iwata, S; Oikawa, T; Saito, N; Sato, Y; Sunakawa, K | 1 |
| Hori, M; Joh, K; Sugita, M; Toyonaga, Y | 1 |
1 trial(s) available for imipenem, anhydrous and Infant, Premature, Diseases
| Article | Year |
|---|---|
[Pharmacokinetic and clinical evaluations of imipenem/cilastatin sodium in neonates and premature infants].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Drug Combinations; Female; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Male; Multicenter Studies as Topic | 1989 |
9 other study(ies) available for imipenem, anhydrous and Infant, Premature, Diseases
| Article | Year |
|---|---|
[Iatrogenic meningitis after diagnosis lumbar puncture: 3 cases reports in the paediatric Children's Hospital of Tunis].
Topics: beta-Lactam Resistance; Brain Abscess; Brain Damage, Chronic; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fosfomycin; Humans; Hydrocephalus; Iatrogenic Disease; Imipenem; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Muscle Hypotonia; Seizures; Serratia Infections; Serratia marcescens; Spinal Puncture; Subdural Effusion; Tunisia | 2011 |
Outbreak of multidrug resistant Acinetobacter in the neonatal intensive care unit.
Topics: Acinetobacter Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Intubation, Intratracheal; Male; Risk Factors; Saudi Arabia; Survival Rate | 2004 |
Safety of imipenem in neonates.
Topics: Dose-Response Relationship, Drug; Humans; Imipenem; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Sepsis; Thienamycins; Treatment Outcome | 1995 |
Quinolone-resistant Salmonella paratyphi B meningitis in a newborn: a case report.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Meningitis, Bacterial; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi B; Thienamycins; Tomography, X-Ray Computed | 1997 |
Pharmacokinetic and clinical evaluation of serious infections in premature and newborn infants under therapy with imipenem/cilastatin.
Topics: Bacteremia; Cilastatin; Dose-Response Relationship, Drug; Female; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Infusions, Intravenous; Intensive Care Units, Neonatal; Male; Prognosis; Protease Inhibitors; Retrospective Studies; Severity of Illness Index; Survival Rate; Thienamycins | 1999 |
Umbilical catheter-related resistant Klebsiella septicaemia in a pre-term infant successfully treated with imipenem via the catheter.
Topics: Bacteremia; Catheterization; Drug Resistance, Microbial; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Klebsiella Infections; Male; Umbilicus | 1992 |
[Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; Cilastatin; Cyclopropanes; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Sepsis; Thienamycins | 1988 |
[Bacteriological and clinical evaluations of imipenem/cilastatin sodium in neonates and premature infants].
Topics: Bacteria; Bacterial Infections; Blood Coagulation; Blood Coagulation Tests; Cilastatin; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Male; Streptococcus agalactiae | 1988 |
[Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in neonates and premature infants].
Topics: Age Factors; Bacterial Infections; Cilastatin; Drug Evaluation; Drug Therapy, Combination; Female; Half-Life; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Infusions, Intravenous; Male | 1988 |